Antithrombin for respiratory distress syndrome in preterm infants

Dirk Bassler1, David Millar2, Barbara Schmidt3
1University Children's Hospital; Department of Neonatology; Tuebingen Germany
2Royal Maternity Hospital; Regional Neonatal Unit; Belfast Northern Ireland Ireland BT12 6BJ
3McMaster University and University of Pennsylvania; Department of Clinical Epidemiology and Biostatistics; Philadelphia Pennsylvania USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Fulia, 2003, Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?, Biology of the Neonate, 83, 1, 10.1159/000067005

Schmidt, 1998, A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome, American Journal of Respiratory and Critical Care Medicine, 158, 470, 10.1164/ajrccm.158.2.9712116

Ambrus, 1990, Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals, Journal of Medicine, 21, 67

Brangenberg, 1997, Antithrombin-III substitution in preterm infants - effects on intracranial hemorrhage and coagulation parameters, Biology of the Neonate, 72, 76, 10.1159/000244469

Muntean, 1989, Antithrombin III concentrate in preterm infants with IRDS: an open, controlled, randomized clinical trial (abstract), Thrombosis and Haemostasis, 62, 288

Yurdakok, 1997, Plasma thrombomodulin, plasminogen activator and plasminogen activator inhibitor levels in preterm infants with or without respiratory distress syndrome, Acta Paediatrica, 86, 1022, 10.1111/j.1651-2227.1997.tb15196.x

Andrew, 1987, Development of the human coagulation system in the full-term infant, Blood, 70, 165, 10.1182/blood.V70.1.165.165

Andrew, 1988, Development of the human coagulation system in the healthy premature infant, Blood, 72, 1651, 10.1182/blood.V72.5.1651.1651

Avery, 1959, Surface properties in relation to atelectasis and hyaline membrane disease, A.M.A. Journal of Diseases of Children, 97, 517

Bick, 2003, Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and Protein S defects, Hematology/oncology Clinics of North America, 17, 9, 10.1016/S0889-8588(02)00101-6

Brus, 1997, Disease severity is correlated with plasma clotting and fibrinolytic and kinin-kallikrein activity in neonatal respiratory distress syndrome, Pediatric Research, 41, 120, 10.1203/00006450-199701000-00019

Hathaway, 1978, Immunologic studies of antithrombin III heparin cofactor in the newborn, Thrombosis and Haemostasis, 39, 624, 10.1055/s-0038-1646736

Malik, 1987, Mechanisms of thrombin-induced lung vascular injury and oedema, American Review of Respiratory Disease, 136, 467, 10.1164/ajrccm/136.2.467

Peters, 1985, Coagulation and fibrinolytic factors in the first week of life in healthy infants, Journal of Pediatrics, 106, 292, 10.1016/S0022-3476(85)80308-5

Roemisch, 2002, Antithrombin: a new look at the actions od a serine protease inhibitor, Blood Coagulation & Fibrinolysis, 13, 657, 10.1097/00001721-200212000-00001

Schmidt, 1992, Thrombin/Antithrombin III complex formation in the neonatal respiratory distress syndrome, American Review of Respiratory Disease, 145, 767, 10.1164/ajrccm/145.4_Pt_1.767

Seeger, 1993, Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity, American Journal of Respiratory Cell and Molecular Biology, 9, 213, 10.1165/ajrcmb/9.2.213

Soll, 1992, Respiratory distress syndrome, Effective care of the newborn infant, 325

Berg, 1989, Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates, European Journal of Pediatrics, 148, 455, 10.1007/BF00595913

Bassler, 2006, Antithrombin for respiratory distress syndrome in preterm infants, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005383.pub2